MeSH D013313 - post-traumatic stress disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
77%27/35
Phase 2
53%38/72
Phase 3
45%21/47
Approved: 7Overall Success rate: 18%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use